Burow's solution (13 per cent aluminium acetate) has been found to inhibit in vitro the growth of most commonly occurring bacteria found in the discharging ear. An in vitro study has shown that the minimum inhibitory concentration of Burow's solution for these organisms lies between a 1:80 and a 1:160 dilution. This paper reports on a clinical trial that incorporated 67 discharging ears to establish the most effective strength of aluminium acetate solution. There was no statistical difference in the effectiveness of full strength Burow's solution compared to 3.25 per cent aluminium acetate solution (a quarter strength Burow's solution). Response rates of 80.8 per cent and 75 per cent respectively following a two-week treatment period were achieved using these two solutions. A 1.3 per cent aluminium acetate solution (1/10 strength Burow's solution) was found to be markedly inferior. Bacteriological and audiological profiles were recorded for each patient.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1258/0022215001906002 | DOI Listing |
Sci Rep
December 2024
College of Resources and Environment, Gansu Agricultural University, Lanzhou, 730070, China.
Cadmium pollution in water is becoming increasingly serious. Thus, the effective removal of Cd(II) from water has garnered attention. Aluminum hydroxide-modified attapulgite (ATP-AC) was prepared from basic aluminum acetate through a coprecipitation method that could efficiently adsorb Cd(II) in aqueous solution.
View Article and Find Full Text PDFYakugaku Zasshi
September 2024
Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University.
Burow's solution is a 13% aluminum acetate solution used for treating chronic suppurative otitis media. However, multiple formulations for Burow's and neo-Burow's solutions are used as in-hospital preparations. Each formulation uses different types and amounts of reagents, and takes a different time to prepare.
View Article and Find Full Text PDFMaterials (Basel)
November 2022
Institute of Construction and Building Materials, Technical University of Darmstadt, 64287 Darmstadt, Germany.
Concrete structures are increasingly becoming exposed to organic acid attack conditions, such as those found in agriculture and food-related industries. This paper aims to experimentally verify the thermodynamic modeling of cement pastes under acetic acid attack. For this, a modeling approach implemented in IPHREEQC via Matlab is described, and results are compared with measured pH and compositions of equilibrated solutions (MP-AES) as well as unreacted/precipitated solids (XRF, XRD and STA) for a wide range of acid concentrations.
View Article and Find Full Text PDFJ Oncol Pharm Pract
April 2023
Department of Radiation Oncology, 6572University of Pennsylvania, Philadelphia, PA, USA.
Introduction: Cyclin-dependent-kinase 4/6(CDK4/6) inhibitors are widely used as a first-line systemic treatment for patients with hormone receptor-positive, human epidermal growth factor receptor-2 negative metastatic breast cancer. Although many patients with metastatic breast cancer require palliative radiotherapy (RT), there are limited data on the safety of combining a CDK4/6 inhibitor with palliative RT.
Case Report: Presented is a case of acute high-grade radiation dermatitis with low-dose palliative RT following administration of palbociclib.
Vet Rec
February 2022
Vellore Village Pet Hospital, Vaughan, Ontario, Canada.
Background: Given the increase in antimicrobial drug resistance of several pathogens that affect the ear, there is a need for alternative therapy for canine otitis externa (OE). We hypothesised that the efficacy of modified Burow's solution would be non-inferior to that of standard treatment with Surolan.
Methods: The treatment success rate of a topical aluminum acetate 2% and betamethasone 0.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!